Introduction {#sec1}
============

Oxidative stress is a common mediator in the development of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, multiple sclerosis and Creutzfeldt-Jacob disease. Increased generation of reactive oxygen species (ROS), Ca^2+^ deregulation, loss of mitochondrial permeability transition pore (MPP), and improper clearance of mitochondria are the major factors which ultimately lead to mitochondrial dysfunction and neuronal oxidative damage. These post-mitotic neurons are extremely sensitive to ROS and thus oxidative stress is associated with apoptosis \[[@cit0001], [@cit0002]\]. Thus, an imbalance in protective mechanisms against such oxidative stress signaling is the main reason for initiation of neuro-toxic effects and degeneration. Endogenous antioxidant defense mechanisms are regulators of oxidative stress. Decrease in antioxidant capacity in neurotoxicity is well established \[[@cit0003], [@cit0004]\]. Improving antioxidant-mediated defense mechanisms is important in modulating oxidative stress and cytoprotection.

Plumbagin is a yellow pigmented secondary metabolite isolated from the roots of *Plumbaginaceae*, *Ancestrocladaceae* and *Dioncophyllaceae* families. The compound is used in treatment of various diseases from ancient times and is identified with multiple functional properties \[[@cit0005]\]. Plumbagin is a potential antioxidant with anti-inflammatory, anti-cancer and radiosensitizing properties \[[@cit0006]--[@cit0009]\]. Numerous studies have reported its role in ameliorating redox signaling and thereby preventing oxidative stress associated damage \[[@cit0010], [@cit0011]\]. In this study, we demonstrate the important role of plumbagin in oxidative stress and inflammatory responses against H~2~O~2~-induced neurotoxic effects in PC12 cells. In order to evaluate the effect, we identified various oxidative stress markers including ROS, nitrite levels, antioxidant status, nuclear localization of transcription factors NF-κB p65 and p-Nrf-2, expression of redox regulators and inflammatory proteins such as nuclear factor κB (NF-κB) p65, cyclooxygenase-2 (COX-2), p-Nrf-2, NAD(P)H quinone dehydrogenase 1 (NQO1), glutathione-s-transferase (GST) and heme oxygenase-1 (HO-1). Further, anti-inflammatory responses were evaluated through pro-inflammatory cytokine levels.

Chemicals {#sec1.1}
---------

RPMI-1640, Fetal Calf Serum, Antibiotic and Antimycolytic solution, DCF-DA and interleukins (IL-6, IL-8 and MCP-1) were purchased from Sigma-Aldrich, China. Primary antibodies were: Nrf-2 (Anti-Nrf2 (phospho S40) antibody, Abcam ab76026), GST (Anti-Glutathione S-Transferase antibody, Abcam ab53942), NQO1 (Anti-NQO1 antibody Abcam (ab34173), HO-1 (Abcam-ab13248), NF-κB p65 (Cell Signaling Technology-Phospho-NF-κB p65 (Ser536)), COX-2 (Abcam-ab15191). Secondary antibodies were purchased from Cell Signaling Technology, Beverly, USA.

Cell culture {#sec1.2}
------------

PC12, pheochromocytoma derived from rat adrenal medulla was procured from American Type Culture Collection (ATCC-CRL-1721). The cells were grown in RPMI-1640 medium supplemented with fetal bovine serum.

Cell viability {#sec1.3}
--------------

The cytotoxic dose of H~2~O~2~ was determined through MTT assay. The cells were cultured and cells in log phase were trypsinised and seeded into a 96-well plate. After overnight attachment of the cells, H~2~O~2~ at different concentrations (10--50 µM) was added and incubated for 24 and 48 h. The cells after the respective treatment schedule were treated with DMSO and dissolved formazan crystals were measured at 570 nm \[[@cit0012]\]. The cell viability was calculated and the IC~50~ value was determined. Protective effect of plumbagin: After attachment, the cells were pre-treated with plumbagin for 24 h (5--25 µM) followed by H~2~O~2~ treatment. The appropriate cytoprotective dose selected was used to study the molecular mechanism involved.

Oxidative stress markers {#sec1.4}
------------------------

### Intracellular ROS generation {#s1d1}

Increased ROS levels initiate oxidative stress. The ROS levels were determined by DCF-DA as described previously \[[@cit0013]\]. PC12 cells were pre-treated with plumbagin (24 h), after which cells were washed with PBS and treated with H~2~O~2~. For determining individual effects, the cells were treated with H~2~O~2~ and plumbagin as a separate group. After the respective treatment schedule, ROS levels were determined spectrophotometrically (480 nm and 520 nm).

### Nitrite estimation {#s1d2}

The nitrite levels were determined using the Nitrite/Nitrate Assay Kit, Sigma-Aldrich (23479).

### Antioxidant enzyme activities {#s1d3}

The specific activity of the antioxidant enzymes was determined using: Superoxide Dismutase Activity Colorimetric Assay Kit (ab65354); Catalase Specific Activity Assay Kit (ab118184), GST Activity Assay Kit (Fluorometric) (ab65325), GPx activity Kit ab102530. The specific activity was calculated and results were expressed as U/mg of protein.

Western blot {#sec1.5}
------------

After the respective treatment schedule, nuclear and whole cell extracts were isolated and used for protein expression through western blot analysis. 30 µg of protein were separated on precast 12% SDS-PAGE gels and transferred to NC membrane. After blocking, primary antibodies (p-Nrf-2, GST, NQO1, HO-1, NF-κB p65, COX-2) were added and incubated overnight. Following TBST wash, appropriate secondary antibodies were added and bands were visualized by the enhanced chemiluminescence (ECL) system. Image J software was used for densitometric analysis of western blots.

Immunofluorescence {#sec1.6}
------------------

The cells were grown on cover slips and coated with lysine. The cells were allowed to attach to the cover slips and treatment was carried out. Plumbagin was administered for 24 h followed by H~2~O~2~ for 3 h. After PBS wash, cells were treated with primary antibody (1 : 50) overnight at 4°C followed by secondary antibody (1 : 2000). Immunofluorescence was carried out for 2 different antibodies, NF-κB-p65 and p-Nrf-2. The images were acquired and nuclear localization was analyzed through Lumi Vision Imager software.

Interleukin expression {#sec1.7}
----------------------

Following treatment with plumbagin and H~2~O~2~, the supernatant was determined for interleukin expression (IL-6, IL-8, and MCP-1); R&D Systems China Co., Ltd.

Statistical analysis {#sec1.8}
--------------------

The data obtained were statistically analyzed using the *t*-test. All the experiments were repeated three times in triplicate.

Results {#sec2}
=======

Plumbagin increases cell viability {#sec2.1}
----------------------------------

[Figure 1 A](#f0001){ref-type="fig"} shows dose-dependent cell death induced by H~2~O~2~ in PC12 neuronal cells. Half maximal inhibitory concentration (IC~50~) value was shown to be 28 µM. Further, the cytoprotective effect of plumbagin was determined by pre-treatment with plumbagin followed by H~2~O~2~ treatment. Plumbagin at a concentration of 20 µM showed a protective effect against H~2~O~2~-induced neurotoxicity ([Figures 1 A, B](#f0001){ref-type="fig"}).

![Plumbagin protects against H~2~O~2~-induced neurotoxicity. Cell viability in the presence of H~2~O~2~ (**A**) and plumbagin (**B**) was analyzed by MTT assay. Results show cell viability (%)\
Data are presented as mean ± SD. ^a^p \< 0.05, ^b^p \< 0.01, compared to control, ^c^p \< 0.05, ^d^p \< 0.01, compared to H~2~O~2~ treatment.](AMS-14-28963-g001){#f0001}

Plumbagin prevents H~2~O~2~ -induced oxidative stress {#sec2.2}
-----------------------------------------------------

H~2~O~2~-induced oxidative stress is well established. In the present study, we identified that plumbagin treatment significantly ameliorated oxidative stress by reducing reactive oxygen species generation and nitrite levels compared to those of H~2~O~2~-treated cells. However, plumbagin and control cells showed non-significant levels of oxidative stress markers ([Figures 2 A, B](#f0002){ref-type="fig"}).

![Plumbagin reduces ROS and nitrite levels. **A** -- Plumbagin reduces H~2~O~2~-induced ROS generation: ROS is expressed in (%) compared to that of control (100%). **B** -- Plumbagin inhibits nitrite levels: the results are expressed in nanomoles of nitrite formed/mg of protein\
Data are presented as mean ± SD. ^b^p \< 0.01, compared to control, ^d^p \< 0.01, compared to H~2~O~2~ treatment.](AMS-14-28963-g002){#f0002}

Plumbagin induces p-Nrf-2 levels and antioxidant defense {#sec2.3}
--------------------------------------------------------

[Figure 3 A](#f0003){ref-type="fig"} shows p-Nrf-2 protein localization in the cytoplasm during H~2~O~2~ treatment; however, plumbagin + H~2~O~2~ treatment resulted in increased nuclear levels compared to the control cells. The expression of p-Nrf-2 and target genes (NQO1, GST, and HO-1) and antioxidant enzyme activities were significantly increased during pre-treatment with plumbagin compared to H~2~O~2~ treatment alone ([Figures 3 B, C](#f0003){ref-type="fig"}).

![Plumbagin improves antioxidant defense: activation of Nrf-2 target proteins. **A** -- Immuno fluorescence of Nrf-2 levels. (Nrf-2-FITC; nucleus stained with DAPI). Scale bar = 100 μm. **B** -- Western blot of Nrf-2 and downstream proteins. **C** -- Antioxidant enzyme activities\
Data are presented as mean ± SD. ^b^p \< 0.01, compared to control, ^d^p \< 0.01, compared to H~2~O~2~ treatment.](AMS-14-28963-g003){#f0003}

Plumbagin reduces NF-κB p65, COX-2 and cytokine levels {#sec2.4}
------------------------------------------------------

We next determined inflammatory effects through nuclear levels of NF-κB p65. Immunofluorescence results showed that H~2~O~2~ increased nuclear migration of NF-κB p65 ([Figure 4 A](#f0004){ref-type="fig"}) and further increased expression of NF-κB p65 and COX-2. Treatment with plumbagin followed by H~2~O~2~ downregulated NF-κB p65 nuclear levels and expression. Further, the downstream target COX-2 expression was suppressed by plumbagin pre-treatment ([Figure 4 B](#f0004){ref-type="fig"}). [Figure 4 C](#f0004){ref-type="fig"} shows significant up-regulation of interleukin levels (IL-6, IL-8, and MCP-1) upon H~2~O~2~ treatment; the increased levels were downregulated by plumbagin treatment.

![Anti-inflammatory effect of plumbagin against H~2~O~2~-induced neurotoxicity. **A** -- Immunofluorescence of NF-kB levels (NF-κB -FITC; nucleus stained with DAPI). Scale bar = 100 μm. **B** -- Western blot of NF-κB and COX-2 expression. **C** -- Interleukin expression. The data are expressed in pg/mg of protein\
Data are presented as mean ± SD. ^a^p \< 0.05, ^b^p \< 0.01, compared to control, ^d^p \< 0.01, compared to H~2~O~2~ treatment.](AMS-14-28963-g004){#f0004}

Discussion {#sec3}
==========

In this study, we showed that plumbagin acted as a potent regulator of H~2~O~2~-induced neurotoxicity by reducing redox signaling and inflammation in PC12 cells. Plumbagin significantly reduced H~2~O~2~-induced cell death and offered cytoprotection by improving the cell viability. H~2~O~2~-induced oxidative stress was reduced by decreasing the ROS levels with a subsequent decline in antioxidant defense mechanisms. Further, plumbagin prevented oxidative stress-induced inflammation by downregulating NF-κB signaling and pro-inflammatory cytokine expressions and up-regulating Nrf-2 driven gene expressions.

In order to understand the neuroprotective properties of plumbagin, we first evaluated the cell death induced by H~2~O~2~ in PC12 cells. H~2~O~2~ dose-dependently induced cell death with an IC~50~ value of 28 µM. Plumbagin pre-treatment significantly improved the cell viability at a concentration ranging from 10 to 25 µM, from which the lowest concentration with the maximum effect was chosen for further studies. Thus, preliminary studies revealed the significant cytoprotective role of plumbagin. Similar neurotoxicity studies have demonstrated that H~2~O~2~ has a prime role in inducing cell death through apoptotic induction in rat cerebral cortex neurons \[[@cit0014], [@cit0015]\]. Next, we studied the detailed molecular mechanism of plumbagin-induced cellular protective mechanisms. Plumbagin prevented H~2~O~2~-induced oxidative stress by reducing the generation of ROS levels and nitrite levels. Further, plumbagin prevented redox signaling through increasing the activation of Nrf-2 and the expression of antioxidant defense system proteins such as HO-1, NQO1, and GST. Plumbagin increased the overall antioxidant status by enhancing the activities of glutathione levels and various enzymic antioxidants: SOD, CAT, GST, GPx. Nrf-2 (nuclear factor erythroid 2 (NF-E2)-related factor 2) belongs to the Cap 'n' Collar (CNC) family of proteins involved in cytoprotective defense and survival. In normal conditions, it is associated with Keap-1 (Kelch-like erythroid cell-derived protein with CNC homology (ECH)-associated protein 1) in the cytoplasm, and upon oxidative insult Nrf-2 localizes into the nucleus, thereby escaping Keap-1 mediated ubiquitination. Inside the nucleus, it associates with small Maf proteins, binds to the antioxidant response element (ARE) and induces transcription of NAD(P)H-quinone oxidoreductase 1 (NQO1), heme oxygenase 1 (HO-1), glutamate-cysteine ligase (GCL) and glutathione-S-transferases (GSTs) \[[@cit0016], [@cit0017]\]. In the present study, we found that H~2~O~2~ prevented the nuclear translocation of p-Nrf-2 and its expression. However, plumbagin significantly prevented these events by inducing nuclear translocation of p-Nrf-2 and increased its expression. In addition, expression of its downstream target proteins such as HO-1, NQO1 and GST was significantly increased during plumbagin pre-treatment. Previous *in vivo* and *in-vitro* studies on plumbagin mediated effects on cerebral ischemia demonstrated the protective role by inducing Nrf-2/ARE signaling and thereby reduced the oxidative insult \[[@cit0018]\]. Thus, plumbagin offers neuroprotection by increasing the antioxidant defense mechanisms.

Down-regulation of Nrf-2 activates inflammatory signaling \[[@cit0019]\]; thus oxidative stress and inflammatory activation are interrelated. In neurodegenerative diseases, activation and sustained inflammatory responses lead to dysfunction of neurons, resulting in disease progression \[[@cit0020], [@cit0021]\]. NF-κB p65 activation induces pro-inflammatory signaling, which results in nuclear translocation and activation of various downstream target proteins including COX-2 and inducible nitric oxide synthase. In the present study, H~2~O~2~ induced NF-κB p65 nuclear translocation and expression with subsequent up-regulation of the inflammatory protein COX-2. However, plumbagin pre-treatment suppressed the inflammation by preventing NF-κB p65 translocation. Further, expression of COX-2 and pro-inflammatory cytokines such as IL-6, IL-8 and MCP-1 was down-regulated. The immunomodulatory effect of plumbagin by suppressing NF-κB signaling was previously reported in ConA-induced inflammation in lymphocytes \[[@cit0006]\]. Plumbagin prevented cellular invasion by activation of the NF-κB pathway and tumor necrosis factor (TNF)-α mediated apoptosis \[[@cit0005]\]. Anti-inflammatory effects of plumbagin were demonstrated in lipopolysaccharides-induced inflammation through suppression of NF-κB and MAPK signaling in Raw 264.7 cells \[[@cit0022]\].

In conclusion, in the present study we demonstrated that plumbagin acts as a neuroprotectant by regulating mechanisms involving both redox signaling and inflammation. Thus, plumbagin might potentially target early activation of ROS and inflammatory proteins, thereby preventing H~2~O~2~-induced neuronal toxicity and damage.
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